Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Update on GEM-91

Feb. 11, 1997

Promising data reported for fomivirsen

Feb. 7, 1997

Hemosol discloses novel cellular immunotherapeutic procedure

Feb. 6, 1997

Japanese researchers develop new HIV protease inhibitors

Feb. 6, 1997

Progenics awarded grants to develop HIV therapeutics

Feb. 4, 1997

Betulinic acid derivatives reported to have anti-HIV activity

Feb. 4, 1997

Preliminary efficacy and safety data for an HIV therapeutic vaccine

Feb. 3, 1997

Ganciclovir prodrug shows potential for treatment of CMV retinitis

Feb. 3, 1997

British scientists describe novel therapeutic approach to HIV

Feb. 3, 1997

PMPA prodrug selected as clinical candidate

Feb. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...